Journal of UOEH
Online ISSN : 2187-2864
Print ISSN : 0387-821X
ISSN-L : 0387-821X
Volume 38, Issue 1
Displaying 1-11 of 11 articles from this issue
  • Mitsuhiro NAKAMOTO, Masanori HISAOKA
    Article type: [Review]
    2016Volume 38Issue 1 Pages 1-8
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Pancreatic cancer is still one of the most lethal malignancies in the world, and a more thorough understanding of its detailed pathogenetic mechanisms and the development of more effective therapeutic strategies are urgently required. Pancreatic ductal adenocarcinoma (PDA), the most common type of pancreatic cancer, is characterized by consistent genetic abnormalities such as point mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) and in the tumor suppressor protein p53 (TP53) genes. Alterations in intracellular core signal pathways have also been shown to induce the development or progression of PDA. The Wingless/int1 (WNT) signal pathway plays a pivotal role in embryonic development, cellular proliferation and differentiation, and dysregulation of WNT signaling can lead to neoplastic transformation in a variety of organ systems, including the pancreas. Recent studies have shown that altered WNT signaling is associated with a poor prognosis in patients with PDA, suggesting that the pathway is a predictor of patients’ survival and a potential therapeutic target of PDA. In this review, the clinicopathological implications of WNT signaling in PDA are highlighted.
    Download PDF (2262K)
  • Toru ISHIDAO, Sumiyo ISHIMATSU, Hajime HORI
    Article type: [Report]
    2016Volume 38Issue 1 Pages 9-16
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Equilibrated vapor concentrations at 25°C of the tetrachloroethylene-chlorobenzene system were obtained in the presence of air to establish a method for estimating vapor concentrations in work environments where multicomponent organic solvents are used. The experimental data were correlated by introducing activity coefficients calculated by the UNIFAC (Universal Quasichemical Functional Group Activity Coefficient) model. There were four interaction parameters between groups in this solution system, and three had already been determined.However, the fourth parameter—the interaction parameter between ACCl and Cl-(C=C) groups—remains unknown. Therefore, this parameter was determined by a nonlinear least-squares method to obtain the best fit for the experimental data. The calculated values were found to be in good agreement with the experimental values.
    Download PDF (2121K)
  • Keigo UCHIMURA, Kei YAMASAKI, Hiroshi ISHIMOTO, Sho KAKINOUCHI, Koki K ...
    Article type: [Original]
    2016Volume 38Issue 1 Pages 17-23
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Endobronchial ultrasonography with a guide sheath (EBUS-GS) has recently been used for improved diagnostic yields for peripheral pulmonary lesions. This study retrospectively evaluated the factors related to the diagnostic yield of EBUS-GS for peripheral lung cancer. The medical records of 76 patients who had been diagnosed with lung cancer and had undergone bronchoscopy with EBUS-GS in our hospital between August 2014 and September 2015 were reviewed. The total diagnostic ratio of peripheral lung cancer was 71.1%. The following factors of the diagnostic yield were evaluated: location of pulmonary lesion; size; feature; bronchus sign; location of EBUS probe; EBUS detection; number of biopsies performed; procedure time; use of virtual bronchoscopic navigation; use of EBUS-guided transbronchial needle aspiration with EBUS-GS; CT slice thickness; operatorʼs years of medical experience; and specialized training in bronchoscopy at the National Cancer Center. In all cases, lesion size ≧ 20 mm (80.8% vs. 50.0%, P = 0.006), EBUS probe location “within” (90.0% vs. 50.0%, P < 0.001), EBUS detection (80.7% vs. 28.6%, P < 0.001), number of biopsies ≧ 5 (78.0% vs. 47.1%, P = 0.013), and bronchoscopy training (81.6% vs. 60.5%, P = 0.043) significantly contributed to an increase in the diagnostic yield. Following a multivariate analysis, EBUS probe location “within” was found to be the most significant factor affecting the diagnostic yield (odds ratio 14.10, 95% CI 3.53-56.60, P < 0.001), and bronchoscopy training was the second most significant factor (odds ratio 6.93, 95% CI 1.86-25.80, P = 0.004). EBUS probe location “within” and bronchoscopy training are the most important factors for improved diagnostic yield by bronchoscopy with EBUS-GS for peripheral lung cancer.
    Download PDF (679K)
  • Akihiro KUMA, Masahito TAMURA, Yutaka OTSUJI
    Article type: [Review]
    2016Volume 38Issue 1 Pages 25-34
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Fibrosis occurs in systemic tissues other than the brain and finally induces dysfunction of the fibrotic organ. Kidney fibrosis is related to scarring after acute kidney injury and the progression of chronic kidney disease. Kidney function decreases with the progression of kidney fibrosis. As fibrotic tissue cannot return to its original status, advanced kidney fibrosis requires the administration of dialysis or kidney transplantation. Thus, elucidation the mechanism of kidney fibrosis is an important research theme. The proliferation and activation of (myo) fibroblasts and the excessive production of an extracellular matrix are common mechanisms in fibrosis in many organs, but it seems that kidney fibrosis has specific pathways. Tubular epithelial, mesangial cells, and erythropoietin producing cells, which exist only in the kidney, participate in forming kidney fibrosis. This review highlights an understanding of the cells and their underlying mechanisms, which are specific to kidney fibrosis process: transforming growth factor-β (TGF-β), epithelial-mesenchymal transition, wingless/int-1 (WNT) signaling, renal anemia, and uremia. Finally, we describe potential therapies that focus on the mechanisms of kidney fibrosis: anti-TGF-β antibody and mammalian target of rapamycin (mTOR).
    Download PDF (1005K)
  • Nobuya HARAYAMA, Shun-Ichi NIHEI, Keiji NAGATA, Keiji AIBARA, Masayuki ...
    Article type: [Review]
    2016Volume 38Issue 1 Pages 35-46
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Early direct current (DC) shock is the most important therapy for ventricular fibrillation. Following the increased availability of automated external defibrillators (AED), the survival rate of cardiopulmonary arrest patients with ventricular fibrillation has improved. Although patients with shock-resistant ventricular fibrillation require additional antiarrhythmic drug therapy, the optimal protocol has not been established. Nifekalant is a pure potassium channel blocker with a pyrimidinedione structure. Nifekalant was approved in Japan for the treatment of life-threatening ventricular tachyarrhythmias in 1999, and is widely used as a class Ⅲ antiarrhythmic intravenous drug. Intravenous amiodarone was approved in Japan in 2007, and exhibits various effects on ion channels, receptors, sympathetic activity, and thyroid function. Nifekalant and amiodarone also exhibit many pharmacological and pharmacodynamic differences. As nifekalant has no negative inotropic effect and a rapid action and clearance with a short half-life, it has some advantages over amiodarone for use in cardiopulmonary resuscitation. Indeed, data from clinical and animal studies suggest that nifekalant is superior to amiodarone for resuscitation of cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. A 300-mg bolus intravenous injection of amiodarone is considered an overdose for resuscitation of shock-resistant ventricular fibrillation. Further clinical studies are required to evaluate the effects of nifekalant compared with amiodarone, and to determine the optimal dose of amiodaone, for resuscitation of shock-resistant ventricular fibrillation.
    Download PDF (1403K)
  • Shuji SOEDA
    Article type: [Report]
    2016Volume 38Issue 1 Pages 47-51
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Though effects of the return-to-work (re-work) program on reinstatement started being reported, factors related to the outcomes are unclear. As a case series, we discuss the outcomes of reinstatement and the characteristics of large-scale assembly-factory workers (our case) who had attended a medical institution’s re-work program. On examining the five successful reinstatement cases and five failed cases, motivation for reinstatement, understanding program requirements, adaptability, and personality traits were found to contribute to these outcomes. We also discussed two failed cases wherein young employees retired after the re-work program. They felt to be disconnected from their work and finally retired.
    Download PDF (633K)
  • Yoshinori INAMASU, Hiroshi ASAUMI, Tatsuyuki WATANABE, Keiichiro KUME, ...
    Article type: [Case Report]
    2016Volume 38Issue 1 Pages 53-59
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Acute superior mesenteric artery (SMA) occlusion is rare and associated with high morbidity and mortality.One of the reasons is the difficulty to diagnose the disease soon after the abdominal pain initially occurs. A 79-year-old woman with atrial fibrillation was admitted because of progressive left abdominal pain and nausea. Two hours after the onset, computed tomography revealed an occlusion of the SMA. No signs of intestinal infarction were present. Abdominal angiography revealed complete obstruction from the distal portion of the SMA to the ileocolic artery, so we could have a diagnosis of SMA occlusion early. Continuous per-catheteric thrombus aspiration for the occlusion successfully removed the thrombus and led to complete revascularization laparotomy. We encountered a case of acute mesenteric ischemia due to SMA occlusion with atrial fibrillation. Early diagnosis is necessary to survive without bowel resection.
    Download PDF (1511K)
  • Rintaro NAKAMURA, Shun-Ichi NIHEI, Hideaki ARAI, Keiji NAGATA, Yasuki ...
    Article type: [Case Report]
    2016Volume 38Issue 1 Pages 61-64
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Although angiotensin-converting enzyme (ACE) inhibitors are widely used as the first choice drug for treating hypertension, we have only a superficial understanding of their relationship to angioedema. We report a case of life-threatening angioedema. The case was a 60-year-old man who had been taking an ACE inhibitor for hypertension for 11 years. He visited his home doctor for dyspnea, and tongue and neck swelling. He was transported to our hospital because of the possibility of airway obstruction. On admission, his tongue and neck swelling became more severe. We performed an intubation using an endoscope and started airway management. We also stopped his ACE inhibitor. The severe tongue and neck swelling improved gradually and he was extubated on day 3. On the fifth day he was discharged. We diagnosed angioedema caused by an ACE inhibitor. Although the risk of airway obstruction with ACE inhibitors is acknowledged, we have only a superficial understanding of how prolonged ACE inhibitor treatment induces angioedema. So we should consider angioedema in cases of taking ACE inhibitors, especially in cases of prolonged treatment.
    Download PDF (10988K)
  • Kosuke MAKIHARA, Tetsuo HAMADA, Kentaro KASAI, Toshiko TANAKA, Hiroaki ...
    Article type: [Case Report]
    2016Volume 38Issue 1 Pages 65-69
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    We had a forensic autopsy case that required additive pathological examination for the asbestos-related lung disease compensatory application afterwards. A man in his sixties with a history of occupational asbestos inhalation who had neither visited a hospital nor received a physical examination received forensic autopsy because of his death from unknown cause. An inmate said, “He developed cough and dyspnea, and died in the progression of the symptoms.” The autopsy revealed widespread pleural plaques on both sides of the parietal pleura and multiple tumors in both sides of the lungs. The cause of death was diagnosed as lung cancer. Additional pathological examination was asked by his family to certify that he had suffered from asbestos-related lung disease in order to apply to the Asbestos-related Damage Relief Law. The Japanese criteria of the compensation law of asbestos-related lung cancer is the detection of more than 5,000 asbestos bodies per gram of dry lung tissue, while his number of asbestos bodies was 4,860. Asbestos bodies were reported to be accumulated in the distal lung parenchyma with no pathological changes. The present lung samples were collected from proximal section around the tumor, which might have made the number of asbestos bodies less than the criteria. Both the number of patients suffering from asbestosrelated lung disease and the number of forensic autopsy cases have increased in Japan. Collecting lung samples from the appropriate lung section is essential and should be noted when the lung cancer is suspected at forensic autopsy in order to apply for asbestos-related lung disease compensation.
    Download PDF (7872K)
  • Yoshinobu ICHIKI, Junji KAWASAKI, Tetsuro YOSHIDA, Takayuki HAMATSU, T ...
    Article type: [Case Report]
    2016Volume 38Issue 1 Pages 71-76
    Published: March 01, 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    The utility of stent placements has been widely reported. We performed a thought-provoking stent placement for malignant tracheal stenosis recently. A 90-year-old woman who was admitted to our hospital because of a urinary tract infection was treated with a course of antibiotics, but she demonstrated a rapidly progressive course with dyspnea. Chest computed tomography showed severe tracheal stenosis due to an upper mediastinal mass. She was put on noninvasive positive pressure ventilation (NPPV) because of severe respiratory failure. Bronchoscopy showed severe tracheal stenosis due to direct invasion by the upper mediastinal mass. An expandable metallic stent (EMS) was placed in the trachea, after which a bronchoscopy showed a widely patent airway, and she got off NPPV. Then she did not need supplemental oxygen. She could seat herself, and have an enough meal, independently. However, takotsubo cardiomyopathy occurred and she died 11 days after the placement of the EMS. Since a malignant airway complication can be fatal, tracheal stent placement is a useful treatment in the management of malignancy with airway stenosis. In this case, it was thought that an early intervention of airway stenosis would have reduced the risk of takotsubo cardiomyopathy in a patient with severe symptoms of airway stenosis and stress.
    Download PDF (4721K)
  • University of Occupational and Environmental Health
    Article type: [Abstracts]
    2016Volume 38Issue 1 Pages 77-117
    Published: 2016
    Released on J-STAGE: March 13, 2016
    JOURNAL FREE ACCESS
    Download PDF (10495K)
feedback
Top